Simran Kaur

Dr Simran Kaur

Senior Biostatistician and Data Sciences Lead

SAIGENCI

College of Health

Dr. Simran Kaur is leading the Data Sciences Unit within the Computational Systems Oncology program at SAiGENCI. Her research focuses on the integration of clinical, genomic, and epidemiological data to investigate disease mechanisms and develop improved genetic risk scores applicable to multi-ethnic populations.
 
Simran completed her PhD in Bioinformatics and Biostatistics in 2015 under the supervision of Professor Flemming Pociot at the University of Copenhagen, Denmark. In her PhD studies, she focused on understanding the genetic architecture of immune-mediated diseases and established computational pipelines to identify and prioritize disease associated non-coding variants. Following her PhD, Simran held postdoctoral and faculty positions at the Steno Diabetes Centre Copenhagen where she investigated roles of aberrantly expressed non-coding RNAs (including miRNAs, lncRNAs and circular RNAs) in pancreatic islets and human pancreatic β-cell lines following pro-inflammatory cytokines exposure. She also contributed to genetic data analysis in several national and international cohorts including the Danish Biobank, DiPiS, DiViD, TEDDY group and INNODIA. Her current interests include computational fine-mapping approaches to disentangle genetic risk and the dissecting HLA-mediated genetic pleiotropy across autoimmune diseases and cancers. As Senior Biostatistician and Data Sciences Lead, Simran collaborates with multidisciplinary teams at SAiGENCI to translate data-driven findings into insights that support precision medicine and improve patient outcomes.
 

  • Appointments
    Date Position Institution name
    2025 - ongoing Senior Biostatistician and Data Science Lead University of Adelaide
    2019 - 2025 Assistant Professor Steno Diabetes Center Copenhagen
    2017 - 2018 Post Doctoral Researcher Steno Diabetes Center
    2015 - 2017 Post Doctoral Researcher Herlev and Gentofte Hospital
    2011 - 2015 PhD fellow University of Copenhagen
    2009 - 2010 Senior Research Fellow National Institute of Pharmaceutical Education and Research
    2007 - 2009 Junior Research Fellow National Institute of Pharmaceutical Education and Research

  • Education
    Date Institution name Country Title
    2011 - 2015 University of Copenhagen Denmark PhD
    2005 - 2007 Panjab University India MSc

  • Research Interests
    Cancer Genetics Statistical and quantitative genetics Genomics and transcriptomics Biomarkers

  • Journals
    Year Citation
    2025 61<sup>st</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : Vienna, Austria, 15 - 19 September 2025. (2025). Diabetologia, 68(Suppl 1), 1-754.
    DOI Europe PMC1
    2025 Mønsted, M., Pedersen, K., Jensen, M. H., Kaur, S., Sustacha, S. C., Holm, L. J., . . . Haupt-Jorgensen, M. (2025). Genetic and transcriptional dysregulation of innate antiviral immune pathways in type 1 diabetes. Immunology Letters, 276, 9 pages.
    DOI
    2025 Joglekar, M. V., Wong, W. K. M., Kunte, P. S., Hardikar, H. P., Kulkarni, R. A., Ahmed, I., . . . Hardikar, A. A. (2025). A microRNA-based dynamic risk score for type 1 diabetes. Nature Medicine, 31(8), 2622-2631.
    DOI Scopus6 WoS6 Europe PMC5
    2025 Yarani, R., Primavera, R., Chetty, S., Wang, J., Kaur, S., Haupt-Jorgensen, M., . . . Thakor, A. S. (2025). Preventing the onset of diabetes with precision delivery of mesenchymal stem cells to the pancreas in a preclinical model.. Stem cell research & therapy.
    DOI
    2024 Syplie, W. (2024). Abstracts of the 2024 Pediatric Endocrine Society (PES) Annual Meeting Abstracts. HORMONE RESEARCH IN PAEDIATRICS, 97(Suppl. 2), 31.
    DOI
    2024 Armenteros, J. J. A., Brorsson, C., Johansen, C. H., Banasik, K., Mazzoni, G., Moulder, R., . . . Brunak, S. (2024). Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study. Diabetes Metabolism Research and Reviews, 40(5), 15 pages.
    DOI Scopus10 WoS10 Europe PMC11
    2024 Greve, J. H., Mørk, F., Jensen, A. K., Kaur, S., Madsen, J. O. B., Bugge, A., . . . Johannesen, J. (2024). Lipid levels in a cohort of healthy Danish schoolchildren ages 5 to 17 years. Scandinavian Journal of Clinical and Laboratory Investigation, 84(4), 285-295.
    DOI
    2024 Marcovecchio, M. L., Hendriks, A. E. J., Delfin, C., Battelino, T., Danne, T., Evans, M. L., . . . Mathieu, C. (2024). The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults. Diabetologia, 67(6), 995-1008.
    DOI Scopus20 WoS19 Europe PMC17
    2024 Joglekar, M. V., Kaur, S., Pociot, F., & Hardikar, A. A. (2024). Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores. The Lancet Diabetes and Endocrinology, 12(7), 483-492.
    DOI Scopus9 WoS8 Europe PMC9
    2023 Mohammadi-Motlagh, H. R., Sadeghalvad, M., Yavari, N., Primavera, R., Soltani, S., Chetty, S., . . . Yarani, R. (2023). β Cell and Autophagy: What Do We Know?. Biomolecules, 13(4), 25 pages.
    DOI Scopus16 WoS17 Europe PMC16
    2023 Frørup, C., Gerwig, R., Svane, C. A. S., Mendes Lopes de Melo, J., Henriksen, K., Fløyel, T., . . . Størling, J. (2023). Characterization of the functional and transcriptomic effects of pro-inflammatory cytokines on human EndoC-βH5 beta cells. Frontiers in Endocrinology, 14, 15 pages.
    DOI Scopus12 WoS13 Europe PMC17
    2023 Rudman, N., Kaur, S., Simunović, V., Kifer, D., Šoić, D., Keser, T., . . . Gornik, O. (2023). Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes. Diabetologia, 66(6), 1071-1083.
    DOI Scopus12 WoS13 Europe PMC14
    2023 Thorsen, S. U., Liu, X., Kataria, Y., Mandrup-Poulsen, T., Kaur, S., Uusitalo, U., . . . Svensson, J. (2023). Interaction Between Dietary Iron Intake and Genetically Determined Iron Overload: Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in the TEDDY Study. Diabetes Care, 46(5), 1014-1018.
    DOI Scopus4 WoS4 Europe PMC4
    2022 Rudman, N., Kifer, D., Kaur, S., Simunović, V., Cvetko, A., Pociot, F., . . . Gornik, O. (2022). Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG. Diabetologia, 65(8), 1315-1327.
    DOI Scopus21 WoS21 Europe PMC21
    2022 Mansachs, S. J., Villumsen, S. O., Johannesen, J., Lind, A., Kaur, S., & Pociot, F. (2022). Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes. Genes, 13(5), 13 pages.
    DOI Scopus3 WoS3 Europe PMC2
    2022 Kaur, S., Frørup, C., Mirza, A. H., Fløyel, T., Yarani, R., Colli, M. L., . . . Pociot, F. (2022). Pro-Inflammatory Cytokines Promote the Transcription of Circular RNAs in Human Pancreatic β Cells. Non Coding RNA, 8(5), 19 pages.
    DOI Scopus2 WoS2 Europe PMC2
    2021 Kaur, S., Mirza, A. H., Overgaard, A. J., Pociot, F., & Størling, J. (2021). A Dual Systems Genetics Approach Identifies Common Genes, Networks, and Pathways for Type 1 and 2 Diabetes in Human Islets. Frontiers in Genetics, 12, 13 pages.
    DOI Scopus16 WoS17 Europe PMC17
    2021 Frørup, C., Mirza, A. H., Yarani, R., Nielsen, L. B., Mathiesen, E. R., Damm, P., . . . Kaur, S. (2021). Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period. Frontiers in Immunology, 12, 11 pages.
    DOI Scopus19 WoS21 Europe PMC19
    2021 Pedersen, K., Haupt-Jorgensen, M., Krogvold, L., Kaur, S., Gerling, I. C., Pociot, F., . . . Buschard, K. (2021). Genetic predisposition in the 2′-5′A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity. Diabetologia, 64(8), 1805-1815.
    DOI Scopus20 WoS20 Europe PMC18
    2021 Fløyel, T., Meyerovich, K., Prause, M. C., Kaur, S., Frørup, C., Mortensen, H. B., . . . Størling, J. (2021). Skap2, a candidate gene for type 1 diabetes, regulates b-cell apoptosis and glycemic control in newly diagnosed patients. Diabetes, 70(2), 464-476.
    DOI Scopus12 WoS12 Europe PMC11
    2021 BRORSSON, C., ARMENTEROS, J. J. A., MAZZONI, G., KAUR, S., SCHULTE, A. M., MATHIEU, C., & BRUNAK, S. (2021). 1111-P: Integrating Longitudinal Clinical and Baseline Multiomics Data for Predicting C-Peptide Progression in Newly Diagnosed Type 1 Diabetes. Diabetes, 70(Supplement_1).
    DOI
    2020 Fløyel, T., Mirza, A. H., Kaur, S., Frørup, C., Yarani, R., Størling, J., & Pociot, F. (2020). The Rac2 GTPase contributes to cathepsin H-mediated protection against cytokine-induced apoptosis in insulin-secreting cells. Molecular and Cellular Endocrinology, 518, 11 pages.
    DOI Scopus15 WoS15 Europe PMC13
    2020 Andersson Svärd, A., Kaur, S., Trôst, K., Suvitaival, T., Lernmark, Å., Maziarz, M., . . . Neiderud, J. (2020). Characterization of plasma lipidomics in adolescent subjects with increased risk for type 1 diabetes in the DiPiS cohort. Metabolomics, 16(10), 14 pages.
    DOI Scopus2 WoS1
    2019 Mirza, A. H., Kaur, S., Nielsen, L. B., Størling, J., Yarani, R., Roursgaard, M., . . . Pociot, F. (2019). Breast milk-derived extracellular vesicles enriched in exosomes from mothers with type 1 diabetes contain aberrant levels of micrornas. Frontiers in Immunology, 10(OCT), 10 pages.
    DOI Scopus99 WoS92 Europe PMC77
    2019 Haas, S., Camm, A. J., Bassand, J. P., Angchaisuksiri, P., Cools, F., Corbalan, R., . . . Li, L. (2019). Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. American Heart Journal, 213, 35-46.
    DOI Scopus44 WoS48 Europe PMC36
    2019 Cools, F., Wollaert, B., Veryoort, G., Verstraete, S., Voet, J., Hermans, K., . . . Worthy, V. (2019). Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry. ACTA CARDIOLOGICA, 74(4), 309-318.
    DOI WoS40 Europe PMC12
    2019 Yasmeen, S., Kaur, S., Mirza, A. H., Brodin, B., Pociot, F., & Kruuse, C. (2019). miRNA-27a-3p and miRNA-222-3p as Novel Modulators of Phosphodiesterase 3a (PDE3A) in Cerebral Microvascular Endothelial Cells. Molecular Neurobiology, 56(8), 5304-5314.
    DOI Scopus35 WoS31 Europe PMC28
    2019 Yarani, R., Mirza, A. H., Kaur, S., & Pociot, F. (2019). Tu1766 – Dysregulated Lncrnas in Inflammatory Bowel Disease Demonstrate Immune System Related Association Through Guilt-By Association Analysis. Gastroenterology, 156(6), S-1116.
    DOI
    2018 Kaur, S., & Pociot, F. (2018). miRNAs regulate development and function of regulatory T-cells in recent onset islet autoimmunity in pre-Type 1 diabetes. Non Coding RNA Investigation, 2(3), 16.
    DOI Scopus3
    2018 Yarani, R., Mirza, A. H., Kaur, S., & Pociot, F. (2018). The emerging role of lncrnas in inflammatory bowel disease. Experimental and Molecular Medicine, 50(12), 14 pages.
    DOI Scopus128 WoS128 Europe PMC108
    2018 Vestergaard, A. L., Bang-Berthelsen, C. H., Fløyel, T., Stahl, J. L., Christen, L., Sotudeh, F. T., . . . Mandrup-Poulsen, T. (2018). MicroRNAs and histone deacetylase inhibition-mediated protection against inflammatory β-cell damage. Plos One, 13(9), 22 pages.
    DOI Scopus19 WoS21 Europe PMC19
    2018 Verheugt, F., Gao, H., Al Mahmeed, W., Ambrosio, G., Angchaisuksiri, P., Atar, D., . . . Li, L. (2018). Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry. European Heart Journal, 39(6), 464-473.
    DOI Scopus42 WoS44 Europe PMC30
    2018 Bassand, J., Accetta, G., Al Mahmeed, W., Corbalan, R., Eikelboom, J., Fitzmaurice, D., . . . Liu, T. (2018). Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation. PLoS ONE, 13(1), e0191592.
    DOI Scopus91 WoS84 Europe PMC77
    2018 Holm, L. J., Krogvold, L., Hasselby, J. P., Kaur, S., Claessens, L. A., Russell, M. A., . . . Buschard, K. (2018). Abnormal islet sphingolipid metabolism in type 1 diabetes. Diabetologia, 61(7), 1650-1661.
    DOI Scopus67 WoS63 Europe PMC63
    2018 Samandari, N., Mirza, A. H., Kaur, S., Hougaard, P., Nielsen, L. B., Fredheim, S., . . . Pociot, F. (2018). Influence of disease duration on circulating levels of miRNAs in children and adolescents with new onset type 1 diabetes. Non Coding RNA, 4(4), E35.
    DOI Scopus26 Europe PMC18
    2018 Nielsen, K. O., Mirza, A. H., Kaur, S., Jacobsen, K. S., Winther, T. N., Glebe, D., . . . Størling, J. (2018). Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cells. Experimental Cell Research, 370(2), 399-408.
    DOI Scopus13 WoS13 Europe PMC11
    2018 Kaur, S., Mirza, A. H., & Pociot, F. (2018). Cell type-selective expression of circular RNAs in human pancreatic islets. Non Coding RNA, 4(4), E38.
    DOI Scopus31 Europe PMC26
    2017 Camm, A., Accetta, G., Ambrosio, G., Atar, D., Bassand, J., Berge, E., . . . Liu, T. (2017). Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation. Heart, 103(4), 307-314.
    DOI Scopus222 WoS215 Europe PMC163
    2017 Fox, K., Lucas, J., Pieper, K., Bassand, J., Camm, A., Fitzmaurice, D., . . . Li, J. (2017). Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. BMJ Open, 7(12), e017157.
    DOI Scopus123 WoS127 Europe PMC90
    2017 Camm, A., Accetta, G., Mahmeed, W., Ambrosio, G., Goldhaber, S., Haas, S., . . . Liu, T. (2017). Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry. BMJ Open, 7(3), e014579.
    DOI Scopus35 WoS39 Europe PMC26
    2017 Mirza, A. H., Kaur, S., & Pociot, F. (2017). Long non-coding RNAs as novel players in β cell function and type 1 diabetes. Human Genomics, 11(1), 10 pages.
    DOI Scopus48 WoS47 Europe PMC40
    2017 Samandari, N., Mirza, A. H., Nielsen, L. B., Kaur, S., Hougaard, P., Fredheim, S., . . . Pociot, F. (2017). Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus. Diabetologia, 60(2), 354-363.
    DOI Scopus67 WoS64 Europe PMC54
    2016 Kaur, S., Mirza, A. H., Brorsson, C. A., Fløyel, T., Størling, J., Mortensen, H. B., . . . Åman, J. (2016). The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus. Molecular and Cellular Endocrinology, 419(C), 83-91.
    DOI Scopus33 WoS31 Europe PMC31
    2016 Pociot, F., Kaur, S., & Nielsen, L. B. (2016). Effects of the genome on immune regulation in type 1 diabetes. Pediatric Diabetes, 17, 37-42.
    DOI Scopus10 WoS9 Europe PMC8
    2016 Overgaard, A. J., Kaur, S., & Pociot, F. (2016). Metabolomic Biomarkers in the Progression to Type 1 Diabetes. Current Diabetes Reports, 16(12), 5 pages.
    DOI Scopus14 WoS14 Europe PMC11
    2016 Brorsson, C. A., Nielsen, L. B., Andersen, M. L., Kaur, S., Bergholdt, R., Hansen, L., . . . Størling, J. (2016). Genetic risk score modelling for disease progression in new-onset type 1 diabetes patients: Increased genetic load of islet-expressed and cytokine-regulated candidate genes predicts poorer glycemic control. Journal of Diabetes Research, 2016, 8 pages.
    DOI Scopus17 WoS17 Europe PMC18
    2016 Bassand, J., Accetta, G., Camm, A., Cools, F., Fitzmaurice, D., Fox, K., . . . Liu, T. (2016). Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. European Heart Journal, 37(38), 2882-2889.
    DOI Scopus248 WoS216 Europe PMC183
    2016 Oh, S., Goto, S., Accetta, G., Angchaisuksiri, P., Camm, A. J., Cools, F., . . . Worthy, V. (2016). Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 223, 543-547.
    DOI WoS60 Europe PMC64
    2015 Lip, G. Y. H., Rushton-Smith, S. K., Goldhaber, S. Z., Fitzmaurice, D. A., Mantovani, L. G., Goto, S., . . . Kakkar, A. K. (2015). Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circulation Cardiovascular Quality and Outcomes, 8(2), S12-S20.
    DOI Scopus79 WoS95 Europe PMC61
    2015 Kaur, S., & Pociot, F. (2015). Alu elements as novel regulators of gene expression in type 1 diabetes susceptibility genes?. Genes, 6(3), 577-591.
    DOI Scopus7 WoS8 Europe PMC5
    2015 Fløyel, T., Kaur, S., & Pociot, F. (2015). Genes Affecting β-Cell Function in Type 1 Diabetes. Current Diabetes Reports, 15(11), 11 pages.
    DOI Scopus46 WoS39 Europe PMC36
    2014 Mirza, A. H., Kaur, S., Brorsson, C. A., & Pociot, F. (2014). Effects of GWAS-associated genetic variants on lncRNAs within IBD and T1D candidate loci. Plos One, 9(8), 15 pages.
    DOI Scopus71 WoS70 Europe PMC60
    2013 Lima, R. T., Barron, G. A., Grabowska, J. A., Bermano, G., Kaur, S., Roy, N., . . . Lin, P. K. T. (2013). Cytotoxicity and cell death mechanisms induced by a novel bisnaphthalimidopropyl derivative against the NCI-H460 non-small lung cancer cell line. Anti Cancer Agents in Medicinal Chemistry, 13(3), 414-421.
    DOI Scopus13 WoS13 Europe PMC8
    2012 Havgaard, J., Kaur, S., & Gorodkin, J. (2012). Comparative ncRNA gene and structure prediction using foldalign and foldalignM. Current Protocols in Bioinformatics, Chapter 12(SUPPL.39), 12.11.1-12.11.15.
    DOI Scopus5 Europe PMC4
    2012 Lima, R. T., Barron, G., Grabowska, J. A., Bermano, G., Kaur, S., Roy, N., . . . Lin, P. K. (2012). Bisnaphthalimidopropyl Derivatives as Antitumor Agents - Targeting SIRT2. EUROPEAN JOURNAL OF CANCER, 48, S243.
    DOI
    2010 Tavares, J., Ouaissi, A., Lin, P. K. T., Loureiro, I., Kaur, S., Roy, N., & Cordeiro-da-Silva, A. (2010). Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1. Chemmedchem, 5(1), 140-147.
    DOI Scopus51 WoS48 Europe PMC38
    2010 Pahwa, S., Kaur, S., Jain, R., & Roy, N. (2010). Structure based design of novel inhibitors for histidinol dehydrogenase from Geotrichum candidum. Bioorganic and Medicinal Chemistry Letters, 20(13), 3972-3976.
    DOI Scopus13 WoS8 Europe PMC8
    2010 Kaur, S., Modi, N. H., Panda, D., & Roy, N. (2010). Probing the binding site of curcumin in Escherichia coli and Bacillus subtilis FtsZ - A structural insight to unveil antibacterial activity of curcumin. European Journal of Medicinal Chemistry, 45(9), 4209-4214.
    DOI Scopus180 WoS160 Europe PMC106
    2010 Kaur, S., Shivange, A. V., & Roy, N. (2010). Structural analysis of trypanosomal sirtuin: An insight for selective drug design. Molecular Diversity, 14(1), 169-178.
    DOI Scopus14 WoS13 Europe PMC10
    2009 Kaur, S., Patel, H., Sharma, V., Garg, P., & Roy, N. (2009). LeishBase: Leishmania major structural database. International Journal of Integrative Biology, 7(2), 63-68.
    Scopus7

  • Book Chapters
    Year Citation
    2020 Kaur, S., Frørup, C., Jensen, V. H., Mirza, A. H., de Melo, J. M. L., Yarani, R., . . . Pociot, F. (2020). Long Noncoding RNAs in Diabetes and β-Cell Regulation. In RNA Technologies (Vol. 11, pp. 523-544). Springer International Publishing.
    DOI Scopus1

  • Conference Papers
    Year Citation
    2024 Berg, A. K., Kaur, S., Storling, J., Thorsen, S. U., Thyssen, J. P., Zachariae, C., & Svensson, J. (2024). Filaggrin mutations and dermatological complications due to diabetes devices. In HORMONE RESEARCH IN PAEDIATRICS Vol. 97 (pp. 58). KARGER.
    2023 Jensen, M. H., Pedersen, K., Kaur, S., Jensen-Dahm, A., Pociot, F., & Haupt-Jorgensen, M. (2023). Pancreatic dysregulation of innate antiviral immune pathways in type 1 diabetes. In DIABETOLOGIA Vol. 66 (pp. S177). GERMANY, Hamburg: SPRINGER.
    2019 Gornik, O., Selak, N., Kaur, S., Kifer, D., Pociot, F., & Morahan, G. (2019). N-glycosylation of plasma proteins is changed in children with early onset type 1 diabetes and regulated by glycosyltransferase and complement C3 genes. In DIABETOLOGIA Vol. 62 (pp. S168). SPAIN, Barcelona: SPRINGER.
    2019 Yarani, R., Mirza, A. H., Kaur, S., & Pociot, F. (2019). DYSREGULATED LNCRNAS IN INFLAMMATORY BOWEL DISEASE DEMONSTRATE IMMUNE SYSTEM RELATED ASSOCIATION THROUGH GUILT-BY ASSOCIATION ANALYSIS. In GASTROENTEROLOGY Vol. 156 (pp. S1116). CA, San Diego: W B SAUNDERS CO-ELSEVIER INC.
    2019 Glyco25, XXV International Symposium on Glycoconjugates (2019). In Glycoconjugate Journal Vol. 36 (pp. 267-397). United States: Springer Science and Business Media LLC.
    DOI Scopus2 Europe PMC2
    2018 Kaur, S., Mirza, A. H., Pociot, F., & Storling, J. (2018). A common regulatory network for type 1 and type 2 diabetes susceptibility genes in human pancreatic islets. In DIABETOLOGIA Vol. 61 (pp. S117). GERMANY, Berlin: SPRINGER.
    2018 Overgaard, A. J., Kaur, S., Ali, A., Weir, J. M., Jayawardana, K., Mortensen, H. B., . . . Pociot, F. (2018). Identification of novel loci associated with lipid levels in recent-onset type 1 diabetes. In DIABETOLOGIA Vol. 61 (pp. S184-S185). GERMANY, Berlin: SPRINGER.
    2018 Floyel, T., Mirza, A. H., Kaur, S., Storling, J., & Pociot, F. (2018). The type 1 diabetes candidate gene CTSH protects against cytokine-induced beta cell apoptosis via Rac2 GTPase. In DIABETOLOGIA Vol. 61 (pp. S200). GERMANY, Berlin: SPRINGER.
    2015 Floyel, T., Mirza, A. H., Kaur, S., & Pociot, F. (2015). The protective effect of cathepsin H on beta cell apoptosis is mediated through the Jak-STAT and NFkappaB signalling pathways. In DIABETOLOGIA Vol. 58 (pp. S200). SWEDEN, Stockholm: SPRINGER.

  • Preprint
    Year Citation
    2024 Joglekar, M., Wong, W. K. M., Kunte, P., Kulkarni, R., Ahmed, I., Farr, R., . . . PREDICT T1D Study Group. (2024). Applicability of a microRNA-based dynamic risk score for type 1 diabetes.
    DOI
    2024 Hardikar, A., Joglekar, M., Wong, W., Kunte, P., Kulkarni, R., Ahmed, I., . . . Pociot, F. (2024). Applicability of a microRNA-based dynamic risk score for type 1 diabetes.
    DOI
    2024 Henriksen, K., Jørgensen, A., Kaur, S., Gerwig, R., Svane, C. A. B., Knop, F., & Størling, J. (2024). Exploring the functional, protective, and transcriptomic effects of GIP on cytokine-exposed human pancreatic islets and EndoC-βH5 cells.
    DOI
    2022 Frørup, C., Gerwig, R., Søndergaard Svane, C. A., Mendes Lopes de Melo, J., Fløyel, T., Pociot, F., . . . Størling, J. (2022). Characterisation of the functional and transcriptomic effects of pro-inflammatory cytokines on human EndoC-βH5 beta cells.
    DOI
    2018 Samandari, N., Mirza, A., Kaur, S., Hougaard, P., Nielsen, L. B., Fredheim, S., . . . Pociot, F. (2018). Influence of Disease Duration on Circulating Levels of miRNAs in Children and Adolescents with New Onset Type 1 Diabetes.
    DOI Europe PMC1

  • Editorial Boards
    Date Role Editorial Board Name Institution Country
    2024 - ongoing Associate Editor Molecular Biology Reports: an international journal on molecular and cellular biology Springer Nature United States
    2023 - ongoing Associate Editor Frontiers in RNA Research Frontiers United States
    2020 - ongoing Editor Frontiers in Genetics Frontiers United States
  • Position: Senior Biostatistician and Data Sciences Lead
  • Email: simran.kaur@adelaide.edu.au
  • Campus: West End Health Precinct
  • Building: AHMS - Adelaide Health and Medical Sciences, floor Ninth Floor
  • Org Unit: South Australian Immunogenomics Cancer Institute
Connect With Me
External Profiles